ARTICLE | Finance
Closing Europe’s largest biotech fund at $630M, Jeito readies to build portfolio
French VC gearing up to build portfolio of European companies focused on severe diseases in small patient populations
September 20, 2021 5:24 AM UTC
After raising Europe’s largest biotech fund at €534 million, French VC Jeito is gearing up to flesh out its portfolio of European companies focused on severe diseases in small patient populations.
According to Jeito Capital founder and CEO Rafaèle Tordjman, it’s the largest European life sciences fund to date, topping LSP’s vintage 2020 fund that closed at $600 million, and the biggest debut fund by an independent VC...